Displaying drugs 15026 - 15050 of 15414 in total
REP8839
REP8839 is a novel methionyl-tRNA synthetase (MetS) inhibitor being developed by Replidyne (GlaxoSmithKline licensed REP8839 to Replidyne in June of 2003).
Investigational
YT-001
Investigational
Matched Iupac: … carbamoyl}-2-hydroxyethyl]carbamoyl}-2-methylpropyl]carbamoyl}ethyl]carbamoyl}-4-tetradecanamidobutanoic acid …
(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene
(1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene is a solid. This compound belongs to the naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings. Known drug targets of (1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene include naphthalene 1,2-dioxygenase subunit beta and naphthalene 1,2-dioxygenase subunit alpha.
Experimental
Matched Description: … (1R, 2S)-cis 1,2 dihydroxy-1,2-dihydronaphthalene include naphthalene 1,2-dioxygenase subunit beta and …
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
Experimental
Illicit
4-Bromo-2,5-dimethoxyphenethylamine
Experimental
Illicit
R048-8071
Experimental
4-Phenylbutylamine
Experimental
2,3-Difluorobenzyl Alcohol
Experimental
Phenethylamine
Experimental
Soneclosan
Experimental
3-Phenylpropylamine
Experimental
2,5-di-tert-butylhydroquinone
Experimental
p-Cumylphenol
Experimental
5-PENTYL-2-PHENOXYPHENOL
Experimental
N-methyl-1-(2-thiophen-2-ylphenyl)methanamine
Experimental
Displaying drugs 15026 - 15050 of 15414 in total